The Claim
Dietary fiber intake is inversely and linearly associated with the risk of metabolic associated steatohepatitis (MASLD), with no threshold below which the association ceases to exist.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher dietary fiber intake is consistently linked to lower risk of MASLD, and even small increases in fiber intake are associated with reduced risk without a minimum threshold.
See the scientific wording
The relationship between dietary fiber intake and MASLD risk follows a linear inverse pattern, with no evidence of a threshold below which fiber becomes ineffective, suggesting that even modest increases in fiber consumption may confer benefit.
When fiber is eaten, gut bacteria break it down to make butyrate, which travels to the liver and turns off genes that cause fat buildup and inflammation, leading to less fat in the liver.
What the research says
1 studyPeople who ate more fiber had less fat in their liver, and the more fiber they ate, the better it was—there was no minimum amount needed to see a benefit, even a little extra fiber helped.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.